2021
DOI: 10.1111/bjh.17625
|View full text |Cite
|
Sign up to set email alerts
|

Non‐pharmacological supportive‐care interventions in acute myeloid leukaemia: a review of randomised controlled trials

Abstract: ADL, activity of daily living; AML, acute myeloid leukaemia; BFI, brief fatigue inventory; EORTC, European organisation for research and treatment of cancer; FACT-F, functional assessment of cancer therapy-fatigue; FVC, forced vital capacity; Gln, glutamine dipeptide; HADS, hospital anxiety and depression scale; H(S)CT, haematopoietic (stem) cell transplantation; HRmax, maximum heart rate; HRR, heart rate reserve; IC induction chemotherapy; IMT, inspiratory muscle training; IV, intravenous; IVC, inspiratory vi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 13 publications
0
3
0
Order By: Relevance
“…The pathogenesis of this disease is complicated and remains obscure. Relevant studies have implied that the occurrence of this disease may also be related to multiple factors, such as the environment, body immune status in addition to genetic factors [17][18][19]. Chemotherapy is the optimal therapeutic regimen, but chemotherapy drugs often cause adverse side effects such as bone marrow suppression, anemia, nausea and vomiting, fatigue, and organ dysfunction, which seriously threaten the life safety of patients [20].…”
Section: Discussionmentioning
confidence: 99%
“…The pathogenesis of this disease is complicated and remains obscure. Relevant studies have implied that the occurrence of this disease may also be related to multiple factors, such as the environment, body immune status in addition to genetic factors [17][18][19]. Chemotherapy is the optimal therapeutic regimen, but chemotherapy drugs often cause adverse side effects such as bone marrow suppression, anemia, nausea and vomiting, fatigue, and organ dysfunction, which seriously threaten the life safety of patients [20].…”
Section: Discussionmentioning
confidence: 99%
“…23 This has led to increasing interest in its potential role in haematological settings; however, few studies of prehabilitation in HCT exist. 24 Additionally, nutrition interventions within prehabilitation studies have been shown to vary, lack detailed description and are often poorly evaluated. 25 Despite the expansion of prehabilitation services to HCT settings, the prehabilitation services currently being delivered in the UK, nutrition practices pre-HCT and the feasibility of nutritional prehabilitation in this context are all poorly understood.…”
Section: Introductionmentioning
confidence: 99%
“…Surgical prehabilitation programmes have been shown to reduce hospital length of stay, infection rates and improve quality of life 23 . This has led to increasing interest in its potential role in haematological settings; however, few studies of prehabilitation in HCT exist 24 . Additionally, nutrition interventions within prehabilitation studies have been shown to vary, lack detailed description and are often poorly evaluated 25 .…”
Section: Introductionmentioning
confidence: 99%